Out-of-sequence placement of donor kidneys to aggressive transplant centers is more likely when the kidneys come from older, donation-after-circulatory death, and hypertensive donors.

In controlled clinical trials, each of several prognostic factors should be balanced across the trial arms. Traditional restricted randomization may be proved inadequate especially with small sample ...